BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:39 PM
 | 
Sep 18, 2012
 |  BC Extra  |  Clinical News

Genomic Health reports data for prostate cancer assay

Genomic Health Inc. (NASDAQ:GHDX) and researchers at the University of California, San Francisco, reported that the Oncotype DX prostate cancer assay met the primary endpoint in a clinical validation study by prospectively predicting adverse...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >